LEGN vs LNTH: Which Stock Is the Better Buy?
Legend Biotech Corporation and Lantheus Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — LEGN vs LNTH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Legend Biotech Corporation (LEGN) | Lantheus Holdings, Inc. (LNTH) | |
|---|---|---|
| Market cap | $6.5B | $6.5B |
| Revenue (latest FY) | $1.03B | $1.54B |
| Net income (latest FY) | $-296.80M | $233.56M |
| Revenue growth (5y CAGR) | 106.4% | 35.3% |
| Net margin | -28.8% | 15.2% |
| Return on equity | -29.6% | 21.4% |
| P/E ratio | — | 24.0 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 7 |
| Positive free cash flow | No | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full LEGN vs LNTH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open LEGN's full financials → Open LNTH's full financials →More comparisons
Frequently asked questions
Which is bigger, LEGN or LNTH?
Lantheus Holdings, Inc. is larger by market capitalization — $6.5B versus $6.5B.
Which grows faster, LEGN or LNTH?
Over the last five fiscal years, Legend Biotech Corporation grew revenue faster — 106.4%/yr versus 35.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.